Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 12:45 AM
NCT ID:
NCT00921167
Eligibility Criteria:
Inclusion Criteria:
* Histologically diagnosed recurrent anaplastic astrocytoma or recurrent glioblastoma multiforme
* At least 18 years of age
* Performance status of 0 and 1 on the Eastern Cooperative Oncology Group (ECOG) criteria
* One or more measurable disease
* Adequate hematologic (neutrophil count \>= 1500/uL, platelets \>= 100,000/uL), hepatic (transaminase =\< upper normal limit (UNL)x2.5, bilirubin level =\< UNLx1.5, alkaline phosphatase =\< UNLx2.5), and renal (creatinine clearance \>= 30mL/min)
* Expected life time more than at least 2 months
* A patients who signed the informed consent prior to the participation in the study
Exclusion Criteria:
* A pregnant or lactating patient
* A patient of childbearing potential without being tested for pregnancy at baseline or with a positive test. (A premenopausal woman with the amenorrhea period of at least 12 months or longer is considered to have non-childbearing potential.)
* A man or woman of childbearing potential without the willingness to use a contraceptive measures during the study
* A patient with history of another malignant disease within past 3 years, except curatively treated basal cell carcinoma of the skin, cervical carcinoma in situ, and early gastric cancer
* Medically uncontrolled serious heart, lung, neurological, psychological, or metabolic disease
* Uncontrolled serious infection
* Enrollment in other study within 30 days
* Hemorrhage on baseline radiologic examination
* A patient who refused to sign the informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00921167
Study Brief:
Protocol Section:
NCT00921167